A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Abroad (travel likely)RecruitingPHASE1

Conditions

Influenza

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Danjiangkou Disease Prevention and Control Center, Wuhan, Hubei, China
Contact: Study coordinator (Yunbo Pan) · 2792320450@qq.com · 86-15897801799

Study leads

Yeqing Tong
Principal Investigator
Hubei Provincial Center for Disease Control and Prevention

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Influenza Prevention · Seasonal Influenza

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Influenza, Human+COVID-19

Abroad (travel likely)RecruitingPHASE1

Anniston, United States · Little Rock, United States

A/Texas Flu Challenge

Influenza

Abroad (travel likely)RecruitingPHASE1

Atlanta, United States · Atlanta, United States

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

Influenza · Viral Respiratory Infection

Abroad (travel likely)RecruitingPHASE1

Moscow, Russia